AMBELVIST ® (gadoquatrane) is a gadolinium-based contrast agent indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and ...
Please provide your email address to receive an email when new articles are posted on . The study analyzed data from 1,224 individuals without and 27 individuals with late-onset epilepsy. Those with ...
GlobalData on MSN
FDA approves Bayer’s Ambelvist contrast agent
The approval is based on global Phase III QUANTI studies evaluating Ambelvist's efficacy and safety in adults and children.
Bayer gets approval for low-dose MRI contrast agent gadoquatrane in US: Berlin Tuesday, June 16, 2026, 12:00 Hrs [IST] Bayer has announced that the US Food and Drug Administration ...
Please provide your email address to receive an email when new articles are posted on . Memory, attention and psychomotor speed were the most frequently affected cognitive domains linked to MRI ...
In a recent study published in The Lancet Regional Health - Europe, researchers performed a prospective case–control study in pregnant women with confirmed coronavirus disease 2019 (COVID-19). They ...
Dr. Lena G. Liu (Neurology): A 58-year-old woman was transferred to this hospital because of progressively worsening confusion and evolving changes on magnetic resonance imaging (MRI) of the head. The ...
A new AI model could help radiologists identify brain abnormalities in MRI scans for all conditions including stroke, multiple sclerosis and brain tumors. The study, led by researchers at King's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results